In the assessment, Viedoc distinguished itself through continued investment in usability, functionality, and geographic coverage. The eClinical suite features Viedoc Clinic, electronic Case Report Form software at the core of the company’s EDC solution, as well as an array of complementary applications that make it easier to build complex studies in a short timeframe, manage the conduct of the trial, and report or export findings with full adherence to regulatory requirements, thereby reducing risk to the study.
"The EDC market has evolved significantly due to the increasing complexity of clinical trials, multiple real-world data sources, and the demand for efficient data management solutions, leading providers to develop comprehensive platforms that integrate data capture with advanced analytics and AI. There is also a clear trend toward enhancing user experience through low-code functionalities to address the need for real-time data insights and improved data accuracy," said Nisarg Shah, Practice Director at Everest Group.
"Viedoc Technologies offers a user-friendly EDC platform with a simple, adaptive interface for eCRF design, data entry, and review. It features a validated system with comprehensive documentation, robust integrations, and native SDTM capabilities. Clients appreciate the affordability of the solution and the responsive customer support. Its expertise in delivering a high-quality, accessible EDC solution with strong support and integration has positioned Viedoc Technologies as a Leader in the Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment 2024."
Over the last 20 years, Viedoc’s eClinical solutions have powered over 7,000 studies with more than 1.6 million subjects across therapeutic areas, countries, languages, and clinical trial phases. With this technology, Viedoc supports patient participation in the right trial at the right time, from anywhere, and with ease-of-use, dependability, and efficiency as core guiding principles.
